Table 3.

Summary table for included studies focused on management.

Authors (year)	Clinical management suggestions
Balajee (2021) [26]	Using RecQL4 as a novel cancer therapeutic target
Ben Dhia et al (2023) [27]	Using dose reduction, regardless of chemotherapy type
Campbell et al (2018) [28]	Using dose reduction regardless of chemotherapy type
Frances and Cordelier (2020) [29]	Using cytidine deaminase as a novel cancer therapeutic target
Jastaniah (2017) [30]	Using rituximab-based chemotherapy protocol
Karalis et al (2011) [31]	Using greater awareness and patient education
Mojumdar (2020) [32]	Using RecQ as a novel cancer therapeutic target
Shen et al (2012) [33]	Using first-apparent cutaneous changes in the face
Walsh et al (2017) [34]	Using effective cancer screening